Read here for latest insights on Serve Robotics (SERV) stock: evaluate its growth with UberEats, financial risks, and market ...

Altimmune’s pemvidutide shows promising Phase IIb MASH results; see key benefits, risks, and a bullish outlook. Read here for ...

Biotech Stocks Are Ready to Rebound. Gilead Sciences and 2 More to Watch Now. The charts show that the group is ready to rally. The drugmaker has become a clear winner with its weight-loss drugs. Now, ...

Uzbekistan Airways will buy up to 22 planes and expand its international routes to the U.S. Lockheed Martin recently unveiled its Vectis collaborate combat aircraft, designed to work autonomous with ...

The $30 in your pocket can go surprisingly far here – maybe toward a set of vintage cocktail glasses, a hand-tooled leather belt, or a piece of Native American pottery. New Mexico’s rich cultural ...

The U.S. stock market has hit a rough patch, yet the S&P 500 index still hasn’t seen a major slump since staging a massive ...

Cadence Design Systems has underperformed the broader market over the past year, but analysts are highly optimistic about the ...

But is a crypto bull market really about to start with gusto, or is the narrative just compelling copy because it promises a euphoric phase of the market just ahead? And how do these predictions fit ...

Despite PTC's weak performance relative to the broader market over the past 52 weeks, Wall Street analysts remain moderately ...

Figma is proving to be a fast-growing AI-powered collaborative design platform, ready for the next phase of expansion.

New live-cell imaging data show that Telomir-1 markedly lowers intracellular iron levels at submicromolar concentrations in human keratinocytes, demonstrating potent cell penetration and ...